Form 8-K - Current report:
SEC Accession No. 0000950170-24-113950
Filing Date
2024-10-10
Accepted
2024-10-10 06:52:27
Documents
12
Period of Report
2024-10-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neog-20241010.htm   iXBRL 8-K 44607
2 EX-99.1 neog-ex99_1.htm EX-99.1 345707
  Complete submission text file 0000950170-24-113950.txt   528671

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20241010.xsd EX-101.SCH 29638
14 EXTRACTED XBRL INSTANCE DOCUMENT neog-20241010_htm.xml XML 4504
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 241363796
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)